Journal for ImmunoTherapy of Cancer (Nov 2023)

765 NG-350A, a tumor-selective anti-CD40 agonist expressing therapeutic, gemcitabine/nab-paclitaxel and ipilimumab for untreated metastatic pancreatic adenocarcinoma: cohort C of the REVOLUTION trial

  • Robert H Vonderheide,
  • Andrew H Ko,
  • Danny Khalil,
  • Oliver Rosen,
  • Robert A Wolff,
  • James Francis,
  • Samantha Bucktrout,
  • Christopher R Cabanski,
  • Silvia Boffo,
  • Zev A Wainberg,
  • Samik Upadhaya,
  • Eileen M O’Reilly,
  • Mark H O’Hara,
  • George Fisher,
  • Jamie Arnott,
  • Ana Rosa Saez-Ibanez,
  • Jay Campbell,
  • Ute Dugan,
  • Jill O’Donnell-Tormey

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0765
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.